Centre Hospitalier Emile Muller

Mulhouse 68100

0 studies enrolling now · 2 studies all time

What they study most

Acute Coronary Syndrome, Multiple Myeloma

Studies at this site

• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab — Stopped early